Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
267 Leser
Artikel bewerten:
(1)

Insight M Promotes David Bercovich to CEO, Gregg Rotenberg to Executive Chairman

Finanznachrichten News

Continued growth and scaling to meet increasing customer demand top priority

SUNNYVALE, CA / ACCESSWIRE / September 10, 2024 / Insight M, the energy industry's leader in high-frequency aerial methane detection, announced today two changes to its executive leadership. David Bercovich, formerly Insight M's Chief Operating Officer, has been chosen to succeed Gregg Rotenberg as the company's Chief Executive Officer, effective September 9, 2024. Rotenberg will move to his previous role of Executive Chairman.

Insight M

Insight M

Bercovich, a founding leader of Google's Enterprise division, has a track record of leadership with growth-stage startups. He has taken several to billion-dollar valuations in roles spanning product management, operations, people operations, business development, and marketing. Prior to joining Insight M, Bercovich was the Chief Operating Officer of Oomnitza, an Enterprise Technology Management SaaS platform, where he led three rounds of funding and an eight-times increase in ARR over a five-year period.

"We all need energy to power our daily lives," said Bercovich. "The key is to make sure that energy is produced and delivered as cleanly and safely as possible. I'm excited to focus on enhancing our methane management products and strategic services that help our customers meet this standard."

"The industry is at an inflection point," said Daniel Palmer, Managing Director of Commercialization at Climate Investment, an investor in Insight M. "Oil and gas operators' need for effective and efficient methane management solutions is rapidly increasing, and David Bercovich has the experience and operational savvy to help Insight M scale to meet this need."

Rotenberg's move to Executive Chairman comes after a successful tenure repositioning the company to meet customer demand for a strategic, evidence-based partner in methane management.

"Gregg Rotenberg has accomplished everything the Board of Directors tasked him with when it appointed him CEO in 2022," said Zachary Bogue, Co-Founder and Managing Partner at DCVC, a deep tech venture capital firm based in Silicon Valley. "He led an overhaul of the senior leadership team and a top-to-bottom rebuild of the company's go-to-market function. As a result, Insight M has tripled its revenue and established itself as an industry leader with a steady flow of new and innovative solutions that continue to gain traction."

###

About Insight M

Founded in 2014, Insight M is a consultative methane emissions management company driven by its unwavering commitment to scientific rigor and overall customer success - it is the energy industry's leader in high-frequency aerial methane detection. Insight M helps oil and gas operators take a pragmatic approach to reducing their emissions - helping them keep gas in the pipe and protect their brand from public and regulatory scrutiny. Insight M's work has saved its oil and gas customers over $500 million in gas value and mitigated over 140 billion cubic feet of methane from entering the atmosphere.

Contact Information

Charlie Feinerman
Sr. Director, Brand & Marketing
charlie@insightm.com
8565778565

Related Files

240910 715 - CEO Transition Press Release

SOURCE: Insight M

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.